MORELLI, Olivia
 Distribuzione geografica
Continente #
NA - Nord America 2.266
EU - Europa 1.853
AS - Asia 1.805
SA - Sud America 296
Continente sconosciuto - Info sul continente non disponibili 137
AF - Africa 31
OC - Oceania 2
Totale 6.390
Nazione #
US - Stati Uniti d'America 2.191
SG - Singapore 809
IT - Italia 301
UA - Ucraina 293
VN - Vietnam 278
IE - Irlanda 274
SE - Svezia 253
BR - Brasile 241
RU - Federazione Russa 227
CN - Cina 222
HK - Hong Kong 211
DE - Germania 145
FR - Francia 112
FI - Finlandia 95
GB - Regno Unito 55
KR - Corea 54
BD - Bangladesh 44
IN - India 42
CA - Canada 31
TR - Turchia 25
AR - Argentina 23
IQ - Iraq 20
MX - Messico 19
AT - Austria 18
PL - Polonia 17
JP - Giappone 16
PK - Pakistan 15
UZ - Uzbekistan 15
BE - Belgio 14
ZA - Sudafrica 13
VE - Venezuela 12
CH - Svizzera 11
ES - Italia 9
NL - Olanda 9
ID - Indonesia 8
JM - Giamaica 8
SA - Arabia Saudita 8
EC - Ecuador 7
PH - Filippine 6
AE - Emirati Arabi Uniti 5
CZ - Repubblica Ceca 5
JO - Giordania 5
MA - Marocco 5
CL - Cile 4
LB - Libano 4
LT - Lituania 4
PS - Palestinian Territory 4
TN - Tunisia 4
DO - Repubblica Dominicana 3
EU - Europa 3
MY - Malesia 3
PY - Paraguay 3
TH - Thailandia 3
AZ - Azerbaigian 2
BH - Bahrain 2
CO - Colombia 2
CR - Costa Rica 2
DM - Dominica 2
GR - Grecia 2
GT - Guatemala 2
HN - Honduras 2
HR - Croazia 2
LV - Lettonia 2
LY - Libia 2
PA - Panama 2
PE - Perù 2
AG - Antigua e Barbuda 1
AL - Albania 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BF - Burkina Faso 1
DK - Danimarca 1
DZ - Algeria 1
EG - Egitto 1
ET - Etiopia 1
GY - Guiana 1
IL - Israele 1
KE - Kenya 1
NP - Nepal 1
NZ - Nuova Zelanda 1
OM - Oman 1
PR - Porto Rico 1
PW - Palau 1
RO - Romania 1
RS - Serbia 1
SC - Seychelles 1
SN - Senegal 1
TJ - Tagikistan 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 6.257
Città #
Singapore 552
Chandler 292
Dublin 274
San Jose 213
Hong Kong 211
Dong Ket 177
San Mateo 141
Jacksonville 114
Boardman 110
Ashburn 102
Santa Clara 97
Moscow 88
Lauterbourg 70
Medford 68
Princeton 68
Ann Arbor 67
Beijing 65
Wilmington 57
Perugia 53
Altamura 50
Seoul 50
Andover 47
Los Angeles 39
Munich 38
New York 32
Lawrence 31
Ho Chi Minh City 30
Piscataway 27
The Dalles 24
Woodbridge 23
Des Moines 22
Hanoi 20
Helsinki 20
Rome 20
São Paulo 18
Frankfurt am Main 16
Saint Petersburg 16
Tokyo 16
Norwalk 15
Brussels 14
Dallas 14
Falls Church 13
Orem 13
Brooklyn 12
Ottawa 11
Turku 11
Chicago 10
Tashkent 10
Curitiba 9
Falkenstein 9
Izmir 9
Milan 9
Nuremberg 9
Rio de Janeiro 9
Warsaw 9
Atlanta 8
Cattolica 8
Columbus 8
Da Nang 8
London 7
San Paolo di Civitate 7
Baghdad 6
Denver 6
Lahore 6
Montreal 6
Mumbai 6
Phoenix 6
Salvador 6
Amman 5
Bologna 5
Foligno 5
Haiphong 5
Houston 5
Mexico City 5
Palermo 5
Porto Alegre 5
Roubaix 5
San Francisco 5
Toronto 5
Amsterdam 4
Ankara 4
Auburn Hills 4
Bari 4
Boston 4
Brasília 4
Buffalo 4
Campinas 4
Cape Town 4
Caracas 4
Chengdu 4
Chennai 4
Fairfield 4
Goiânia 4
Johannesburg 4
Kingston 4
Manchester 4
Manila 4
Naples 4
Redwood City 4
Reggio Emilia 4
Totale 3.771
Nome #
Acalasia esofagea: Caso clinico 159
5-ASA-glutamate protects rats from inflammaory bowel disease induced by intracolonic administration of trinitrobenzensulfonic acid. 147
Pasta naturally enriched with isoflavone aglycons from soy germ reduces serum lipids and improves markers of cardiovascular risk. 144
A new amino acid derivative of ursodeoxycholate, (N-L-Glutamyl)-UDCA (UDCA-Glu), to selectively release UDCA in the colon. 134
Acute appendicitis due to Cytomegalovirus in an apparently immunocompetent patient: a case report 128
Administration of isoflavones enriched pasta reduces gastric emptying time in healthy volunteers 117
Acalasia esofagea: Caso clinico 112
A simplified method for anal ultrasonography: preliminary report 112
Ultrasonographic assessment of colonic wall in moderate-severe ulcerative colitis: comparison with endoscopic findings 109
NO-aspirin protects from T cell-mediated liver injury by inhibiting caspase-dependent processing of Th1-like cytokines 106
A new aminoacid derivative of ursodeoxycholate, N-L-glutamyl-UDCA (UDCA-glu) to release selectively UDCA in the rat colon. 103
APPROCCIO AL PAZIENTE CON DIARREA 101
Administration of 3 alpha-6 alpha-dihydroxy-7a alpha-fluoro-5 beta-cholanoate (UPF-680) in chronic cholestasis induced by 17 alpha-ethynyl-estradiol (17 alpha EE) in rats. 101
NCX-1000, a NO-releasing derivative of ursodeoxycholic acid, selectively delivers NO to the liver and protects against development of portal hypertension 98
SINDROMI POST-GASTRECTOMIAE POST-VAGOTOMIA. 95
NO-NSAIDs are ICE/caspase1 inhibitors and protect from citokine-mediated acute liver failure induced by Concanavalin A in mice. 95
Approccio al paziente con gas e meteorismo 93
Indomethacin modulates Mac-1 expression on circulating neutrophils by inducing Ca2+ mobilization and tyrosine kinase activation. 93
Soy germ-enriched pasta containing isoflavones ameriorates gastric emptying time in diabetic patients. 93
AN UNUSUALLY RAPID-ONSET PORTAL HYPERTENSION 92
Pathogenesis of non-steroidal anti-inflammatory drug gastropathy 92
LESIONI FOCALI EPATICHE MALIGNE 91
NCX 1000, an NO-derivative of ursodeoxycholic acid protects against Th1-mediated liver damage in mice. 90
Amino acid derivatives of UDCA as novel prodrugs for colonic-specific drug delivery. 89
Nitric oxide-releasing NSAIDs inhibit interleukin 1beta converting enzyme-like cysteine proteases and protect endothelial cells from appopthosis induced by TNFx 88
NSAID-induced TNF alpha release from macrophages is the key mediator of gastric mucosal injury. 86
Trattamento farmacologico della gastropatia da FANS. 84
Association between celiac disease and chronic hepatitis C 84
TNFalpha processing enzyme inhibitors prevent aspirin-induced TNFalpha release and protect against gastric mucosal injury in rats. 83
Nitric oxide-derived NSAIDs inhibit ICE-like Cysteine Proteases, IL-1β and IFNγ release and protect from Concanavallin A-induced acute liver injury 83
Nitric Oxide-derived NSAIDs inhibit ICE-like Cysteine Proteasis and protect from acute liver injury in a mice model of T-cell mediated hepatitis 83
An NO-derivative of ursodeoxycholic acid exerts Anti-apoptotic effects by inhibiting Fas-dependent activation of liver caspases 82
Isoflavones in Soy-Germ Pasta Modulate the Expression of Human Gastric Genes Involved in Mucosal Defense 82
Gastroparesis: New insights into an old disease 82
Malattie ereditarie del pancres 80
Colon and gastric metastases from a primary signet-ring cell carcinoma of the urinary bladder. 80
NCX-1000, an NO derivative of UDCA, releases NO and protects against portal hypertension by inhibiting hepatic stellate cell contraction. 80
Soy extract diet in rats to decrease liver steatosis induced by lieber-de carli modified diet 80
Advanced hepatocellular carcynoma: treatment with all-trans retinoic acid (ATRA) plus tomoxifen and vitamin E 80
Predictors of serious adverse events and non-response in cirrhotic patients with primary biliary cholangitis treated with obeticholic acid 78
Twenty-four-hour manometric study of colonic propulsive activity in patients with diarrhea due to inflammatory (ulcerative colitis) and non-inflammatory (irritable bowel syndrome) conditions. 77
Acalasia esofagea: caso clinico 77
Real-time determination of gastric juice pH with EndoFaster® for atrophic gastritis assessment 76
TNF alpha processing enzyme inhibitors prevent aspirin-induced TNF alpha release and protect against gastric mucosal injury in rats. 75
Acalasia Esofagea: caso clinico 75
Fattori di rischio della gastropatia da FANS 74
NO-NSAID gastrointestinal safety is related to inhibition of ICE-like Cysteine Proteases. New insights into the moleculare basis of NSAID gastropathy 74
Effect of NO donors and NO-aspirin on TNF release and gastric mucosal damage in rats and isolated macrophages 74
Gastrointestinal safety of nitric oxide-derived aspirin is related to inhibition of ICE-like cysteine proteases in rats 72
A pilot study with all-trans retinoic acid plus tamoxifen and vitamin E in patients with hepatocellular carcinoma (HCC): a four years follow-up 72
Rectal bleeding due to ectopic variceal bleeding: the "emborrhoid'' technique as a bridge to TIPS placement 72
S.Fiorucci, E. Antonelli, O. Morelli, B.Federici, and A.Morelli. Prevention of gastric damage by NO-releasing aspirin (NCX-4016) is mediated by inhibition ICE-Like proteases in gastric mucosa and endothelial cells 70
Upper Gastrointestinal Endoscopy Quality in Italy: A Nationwide Study 68
Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis 68
Clinical and endoscopic findings in patients with acute gastrointestinal bleeding associated with direct oral anticoagulants: Results from a single-center prospective cohort study 68
Macri’ G, Surrenti E, Ciancio G, Morelli O, Pignalosa P, Galli A, Salvadori G, Surrenti C. Amoxicillin, Clarithromycin, Azithromycin and Tinidazole for the eradication of Helicobacter pylori (Hp) infection in peptic ulcer patients: a random clinical trial 66
Isoflavones in food with minimal soy protein reduce serum cholesterol and improve important markers of cardiovascular risk. 66
Nitric oxide-releasing NSAIDs inhibit interleukin-1 beta converting enzyme-like cysteine proteases and protect endothelial cells from apoptosis induced by TNF alpha 65
Real-time gastric juice analysis with EndoFaster for H. pylori diagnosis: A large, multicentre study 64
Treatment with all-trans retinoic acid plus tamoxifen and vitamin E in advanced hepatocellular carcinoma. 62
In vivo bombesin-stimulated pancreatic growth is mediated by direct angiogenetic effect on endothelial cells 62
Lesioni epatiche benigne 62
An Italian prospective multicenter survey on patients suspected of having non-celiac gluten sensitivity 60
Endoscopic ultrasonography-guided biliary drainage for malignant jaundice by using electrocautery-enhanced lumen-apposing metal stents (Hot-SPAXUS stent) 59
PATOLOGIA MOTORIA E INFIAMMATORIA DELL’ESOFAGO: CASO CLINICO. 59
Oral anticoagulants and small intestinal bacterial overgrowth. 59
Lesioni focali epatiche benigne 54
Inteleukin-10 reduces lethality and hepatic injury induced by lipopolysaccharide (LPS) in D-galactosamine (Galn) sensitized mice. 54
Treatment strategy of hepatocellular carcinoma: Comparison between percutaneous ethanol injection and radiofrequency ablation. A three-year follow-up study 54
Platelet count does not predict bleeding in cirrhotic patients: Results from the PRO-LIVER Study 53
Small intestinal bacterial overgrowth and warfarin dose requirement variability. 53
Upper endoscopy in elderly patients: a multicentre, cross-sectional study 52
Expression of Platelet-Derived Growth Factor (PDGF) and Platelet Derived Growth Factor Receptor (PDGF-R) in a cholestatic model of rat liver fibrosis. 49
The single photon emission tomography proves a reduction of cerebral blood flow in cirrhotic patients before the appearance of overt encephalopathy. 48
Treatment of All-Trans Retinoic Acid (ATRA) plus Tamoxifen and Vitamin E in patients with advanced hepatocellular carcynoma 47
Portal vein thrombosis relevance on liver cirrhosis: Italian Venous Thrombotic Events Registry 45
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 45
EGF modulates Pepsinogen secretion in gastric isolated chief cells by activating multiple intracellular pathway. 43
Update on ozanimod for ulcerative colitis 42
Zygomycosis in Italy: A survey of FIMUA-ECMM (Federazione Italiana di Micopatologia Umana ed Animale and European Confederation of Medical Mycology) 41
The environmental impact of pediatric celiac disease diagnosis and follow‐up 25
Totale 6.390
Categoria #
all - tutte 29.367
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.367


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022528 0 102 9 41 20 10 10 185 10 4 57 80
2022/2023938 74 140 11 76 71 107 2 45 358 11 30 13
2023/2024333 20 45 22 9 4 3 60 7 39 18 54 52
2024/20251.061 5 105 48 33 179 55 82 88 149 53 183 81
2025/20262.041 157 194 119 228 247 168 323 97 226 165 87 30
2026/202792 34 58 0 0 0 0 0 0 0 0 0 0
Totale 6.390